Tag: cancer risk

31 October 2025

Kellen Gardner 1

TNF Inhibitors and Cancer Risk: What You Need to Know About Biologics and Immunosuppression

TNF inhibitors help control autoimmune diseases but raise questions about cancer risk. Learn what the latest data says about skin cancer, lymphoma, and whether adalimumab is riskier than etanercept - with real-world guidance for patients.

Random posts

Ovarian Cancer and Sexuality: Practical Ways to Keep Intimacy Healthy
Discover how ovarian cancer affects intimacy and learn practical strategies-communication tips, physical aids, and professional resources-to keep your relationship close and fulfilling.
Entocort (Budesonide) vs Other IBD Treatments: A Practical Comparison
Explore how Entocort (budesonide) stacks up against other IBD therapies. Get clear comparisons, side‑effect insights, and guidance on choosing the right option.
Leukeran (Chlorambucil) vs Top Alternatives: Pros, Cons & When to Switch
Compare Leukeran (chlorambucil) with top alternatives, covering effectiveness, side effects, costs, and how to choose the right option for CLL and lymphoma.
Rheumatoid Arthritis Medications: How DMARDs and Biologics Interact in Treatment
Rheumatoid arthritis treatment relies on DMARDs and biologics to control inflammation and prevent joint damage. Learn how methotrexate, biologics, and JAK inhibitors work together, their risks, costs, and what real patients experience.
Nimodipine for PTSD: How It Works and What the Evidence Shows
Explore how nimodipine, a brain‑targeting calcium channel blocker, may help ease PTSD symptoms, the science behind it, and what current studies reveal.